Blockade of T-type Ca2+ channels inhibits human ovarian cancer cell proliferation

Cancer Investigation

Volumn 29, Issue 5, 2011, Pages 339-346

  Li, Wei ^a   Zhang, Shu Lan ^a   Wang, Ning ^a   Zhang, Bin Bin ^a   Li, Ming ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cell cycle; HO8910; Ovarian cancer; Proliferation; siRNA; T type Ca2+ channel; Xenograft nude mice

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; MIBEFRADIL; NNC 55 0396; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM ANTAGONISM; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL LINE, TUMOR; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; CYCLOPROPANES; FEMALE; HUMANS; MIBEFRADIL; MICE; MICE, NUDE; NAPHTHALENES; OVARIAN NEOPLASMS; RNA INTERFERENCE; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79957508250     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.568565     Document Type: Article

References (33)

1. Rosado JA, Redondo PC, Pariente JA, Salido GM. Calcium signaling and tumorigenesis. Cancer Ther 2004;2: 263-270
2. Gackiere, F, Bidaux, G, Delcourt, P, Van Coppenolle, F, Katsogiannou, M, Dewailly E, Bavencoffe, A, Van Chuoi-Mariot MT, Mauroy, B, Prevarskaya, N, Mariot P. CaV32 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J Biol Chem 2008;283: 10162-10173
3. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005;205: 159-173 (Pubitemid 41803693)
4. 2+ transport. Nat Rev Cancer 2007;7: 519-530 (Pubitemid 46985398)
5. Prevarskaya, N, Skryma, R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 2010;16: 107-121
6. Taylor JT, Zeng XB, Pottle JE, Lee, K, Wang AR, Yi SG, Scruggs JA, Sikka SS, Li M. Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 2008;14: 4984-4991
7. 2+ channel in hepatocellular carcinoma cell proliferation. Oncol Rep 2009;22: 1229-1235
8. Meissner, A, Noack T. Proliferation of human lens epithelial cells (HLE-B3) is inhibited by blocking of voltage-gated calcium channels. Pflugers Arch 2008;457: 47-59
9. Mulgrew CJ, Cove-Smith, A, McLatchie LM, Brooks, G, Shattock MJ, Hendry BM. Inhibition of human mesangial cell proliferation by targeting T-type calcium channels. Nephron Exp Nephrol 2009;113: e77-e88
10. 2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 2008;267: 116-124
11. Armstrong CM, Matteson DR. Two distinct populations of calcium channels in a clonal line of pituitary cells. Science 1985;227: 65-67 (Pubitemid 15156217)
12. Le Guennec JY, Ouadid-Ahidouch, H, Soriani, O, Besson, P, Ahidouch, A, Vandier C. Voltage-gated ion channels, new targets in anti-cancer research. Recent Pat Anticancer Drug Discov 2007;2: 189-202
13. Panner, A,Wurster RD. T-type calcium channels and tumor proliferation. Cell Calcium 2006;40: 253-259 (Pubitemid 43942305)
14. Li,M, Hansen JB, Huang, L, Keyser BM, Taylor JT. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC55-0396 Cardiovasc Drug Rev 2005;23: 173-196 (Pubitemid 41278975)
15. 2+ channel gene family. Circ Res 1998;83: 103-109 (Pubitemid 28322104)
16. Monteil, A, Chemin, J, Bourinet, E, Mennessier, G, Lory, P, Nargeot J. Molecular and functional properties of the human alpha( 1G) subunit that forms T-type calcium channels. J Biol Chem 2000;275: 6090-6100 (Pubitemid 30129892)
17. Monteil, A, Chemin, J, Leuranguer, V, Altier, C, Mennessier, G, Bourinet, E, Lory, P, Nargeot J. Specific properties of T-type calcium channels generated by the human alpha 1I subunit. J Biol Chem 2000;275: 16530-16535 (Pubitemid 30398876)
18. Latour, I, Louw DF, Beedle AM, Hamid, J, Sutherland GR, Zamponi GW. Expression of T-type calcium channel splice variants in human glioma. Glia 2004;48: 112-119 (Pubitemid 39545943)
19. Toyota, M, Ho, C, Ohe-Toyota, M, Baylin SB, Issa JP. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5- CpG island in human tumors. Cancer Res 1999;59: 4535-4541 (Pubitemid 29428953)
20. 2+ entry. Cancer Res 2000;60: 1002-1008 (Pubitemid 30129537)
21. 2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 2002;62: 210-219 (Pubitemid 34804099)
22. 2+ channel blockers suppress the growth of human cancer cells. Bioorg Med Chem Lett 2008;18: 3899-3901
23. Yang, Q, Sakurai, T, Mori, I, Yoshimura, G,Nakamura, M, Nakamura, Y, Suzuma, T, Tamaki, T, Umemura, T, Kakudo K. Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer 2001;92: 54-60 (Pubitemid 32623040)
24. Zou, H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero, Y, Burgart LJ, Ahlquist DA. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 2005;116: 584-591 (Pubitemid 41099195)
25. + channels inhibits progression of human endometrial cancer. Oncogene 2007;26: 5107-5114 (Pubitemid 47206942)
26. 2+ channel expression in human esophageal carcinomas, a functional role in proliferation.CellCalcium 2008;43: 49-58
27. Panner, A, Cribbs LL, Zainelli GM, Origitano TC, Singh, S, Wurster RD. Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 2005;37: 105-119 (Pubitemid 40017369)
28. Steinhardt RA, Alderton J. Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature 1988;332: 364-366
29. Hsu YF, Lee TS, Lin SY, Hsu SP, Juan SH, Hsu YH, Zhong WB, LeeWS. Involvement of Ras/Raf-1/ERK actions in the magnololinduced upregulation of p21 and cell-cycle arrest in colon cancer cells. Mol Carcinog 2007;46: 275-283
30. Tsukamoto, I, Kojo S. Effect of calcium channel blockers and trifluoperazine on rat liver regeneration. Eur J Pharmacol 1987;14g4: 159-162 (Pubitemid 18011196)
31. Fan, H, Villegas, C,Wright JA. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential. Proc Natl Acad Sci USA 1996;93: 14036-14040 (Pubitemid 26424241)
32. Lopez-Girona, A, Colomer, J, Pujol MJ, Bachs, O, Agell N. Calmodulin regulates DNA polymerase alpha activity during proliferative activation of NRK cells. Biochem Biophys Res Commun 1992;184: 1517-1523
33. Sachs HG, Stambrook PJ, Ebert JD. Changes in membrane potential during the cell cycle. Exp Cell Res 1974;83: 362-366